Dare Bioscience (DARE) Stock Surges On Bill & Melinda Gates Foundation Grant

Dare Bioscience (NASDAQ: DARE) shares are surging premarket after the company was awarded a new grant of up to $48.95 million from the Bill & Melinda Gates Foundation.

The grant is to help support the technology development and preclinical activities to advance DARE-LARC1 toward clinical testing in humans.

DARE-LARC1 is the company’s investigational user-controlled, long-acting reversible contraceptive.

WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.

Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.

5.0

Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

An initial payment of $11.45 million will be paid in July, with additional payments contingent on the DARE-LARC1 program’s achievement of specified development and reporting milestones.

Dare Bioscience’s share price has jumped 56.5% to $2.38 premarket on the news.

Should You Invest in Dare Bioscience Shares?

One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now